Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation

Transfusion

Volumn 48, Issue 1, 2008, Pages 163-168

  Wirk, Baldeep ^b   Klumpp, Thomas R ^a   Ulicny, John ^b   Herman, Jay H ^b   Gajewski, James L ^b   Martin, Mary E ^b   Emmons, Robert V B ^b   Mangan, Kenneth F ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD GROUP RHESUS SYSTEM; CHRONIC GRAFT VERSUS HOST DISEASE; DISEASE FREE SURVIVAL; DONOR SELECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; RHESUS INCOMPATIBILITY; RISK FACTOR; SURVIVAL RATE;

ADULT; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RH-HR BLOOD-GROUP SYSTEM; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 37549042053     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01501.x     Document Type: Article

References (22)

1. Klumpp TR. Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant 1991 8 : 159 70.
2. Klumpp TR, Herman JH, Ulicny J, Emmons RV, Martin ME, Mangan KF. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006 38 : 615 20.
3. Seebach JD, Stussi G, Passweg JR, Loberiza FR Jr, Gajewski JL, Keating A, Goerner M, Rowlings PA, Tiberghien P, Elfenbein GJ, Gale RP, van Rood JJ, Reddy V, Gluckman E, Bolwell BJ, Klumpp TR, Horowitz MM, Ringdén O, Barrett AJ GVHD Working Committee of Center for International Blood and Marrow Transplant Research. ABO blood group barrier in allogeneic bone marrow transplantation revisted. Biol Blood Marrow Transplant 2005 11 : 1006 13.
4. Hows J, Beddow K, Gordon-Smith E, Branch DR, Spruce W, Sniecinski I, Krance RA, Petz LD. Donor derived red cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 1986 67 : 177 81.
5. Erker CG, Steins MB, Fischer RJ, Kienast J, Berdel WE, Sibrowski W, Cassens U. The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation. Transfusion 2005 45 : 1382 90.
6. Klumpp TR. Sample size requirement for randomized studies of neutrophil engraftment rate. Blood 1997 90 (10 Suppl 1 361b.
7. Parimon T, Au DH, Martin PJ, Chien JW. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 2006 144 : 407 14.
8. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995 15 : 825 8.
9. Sullivan KM. Graft-versus-host disease. In : Blume KG, Forman SJ, Appelbaum FR, editors. Thomas' hematopoietic cell transplantation. Oxford : Blackwell Publishing Ltd 2004. p. 635 64.
10. Hochberg Y. A sharper Bonferroni procedure for multiple significance testing. Biometrika 1988 75 : 800 3.
11. Jakobowicz R, Williams L, Silberman F. Immunization of Rh-negative volunteers by repeated injections of very small amounts of Rh-positive blood. Vox Sang 1972 23 : 376 81.
12. Ramasethu J, Luban NL. Alloimmune hemolytic disease of the newborn. In : Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, editors. Williams hematology. New York : McGraw-Hill 2001. p. 665 75.
13. Baldwin ML, Ness PM, Scott D, Braine H, Kickler TS. Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients. Transfusion 1988 18 : 330 3.
14. Goldfinger D, McGinniss MH. Rh-incompatible platelet transfusions - risks and consequences of sensitizing immunosuppressed patients. N Engl J Med 1971 284 : 942 4.
15. Cid J, Ortin X, Elies E, Castella D, Panades M, Martin-Vega C. Absences of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions. Transfusion 2002 42 : 173 6.
16. Lichtiger B, Surgeon J, Rhorer S. Rh-incompatible platelet transfusion therapy in cancer patients. A study of 30 cases. Vox Sang 1983 45 : 139 43.
17. McLeod BC, Piehl MR, Sassetti RJ. Alloimmunization to RhD by platelet transfusion in autologous bone marrow transplant recipients. Vox Sang 1990 59 : 185 9.
18. Cummins D, Contreras M, Amin S, Halil O, Downham B, Yacoub MH. Red cell alloantibody development associated with heart and lung transplant. Transplantation 1995 59 : 1432 5.
19. McCullough J. Transfusion therapy in specific clinical situations. In : Mccullough J, editor. Transfusion medicine. New York : McGraw-Hill 1998. p. 290.
20. Esteve J, Alcorta I, Pereira A, Carreras E, Rozman C. Anti-D antibody of exclusive IgM class after minor Rh(D)-mismatched BMT. Bone Marrow Transplant 1995 16 : 632 3.
21. Atkinson K. Reconstruction of hemopoietic and immune system after marrow transplantation. Bone Marrow Transplant 1990 5 : 209 26.
22. Cid J, Lozano M, Fernández-Avilés F, Carreras E, Pereira A, Mazzara R, Ordinas A. Anti-D alloimmunization after D-mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases. Transfusion 2006 46 : 169 73.